Search filters

Phase 1 dose-escalation study of momelotinib, a Janus kinase 1/2 inhibitor, combined with gemcitabine and nab-paclitaxel in patients with previously untreated metastatic pancreatic ductal adenocarcinoma.

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published on 30 July 2018
Author/s

author: David A Barbie  William C Hahn  Kimmie Ng  Charles S. Fuchs 

Publication date July 30, 2018
Language
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item